These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The association between diabetic complications and exercise capacity in NIDDM patients. Estacio RO, Regensteiner JG, Wolfel EE, Jeffers B, Dickenson M, Schrier RW. Diabetes Care; 1998 Feb; 21(2):291-5. PubMed ID: 9539998 [Abstract] [Full Text] [Related]
3. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy. Chen J, Gall MA, Yokoyama H, Jensen JS, Deckert M, Parving HH. Diabetes Care; 1996 Feb; 19(2):130-4. PubMed ID: 8718432 [Abstract] [Full Text] [Related]
4. Prevalence and associated features of albuminuria in Koreans with NIDDM. Lee KU, Park JY, Kim SW, Lee MH, Kim GS, Park SK, Park JS. Diabetes Care; 1995 Jun; 18(6):793-9. PubMed ID: 7555505 [Abstract] [Full Text] [Related]
5. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M. Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918 [Abstract] [Full Text] [Related]
6. Retinopathy as a predictor of other diabetic complications. El-Asrar AM, Al-Rubeaan KA, Al-Amro SA, Moharram OA, Kangave D. Int Ophthalmol; 2001 May; 24(1):1-11. PubMed ID: 11998880 [Abstract] [Full Text] [Related]
7. Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. The Italian NIDDM Nephropathy Study Group. Faronato PP, Maioli M, Tonolo G, Brocco E, Noventa F, Piarulli F, Abaterusso C, Modena F, de Bigontina G, Velussi M, Inchiostro S, Santeusanio F, Bueti A, Nosadini R. Diabetologia; 1997 Jul; 40(7):816-23. PubMed ID: 9243103 [Abstract] [Full Text] [Related]
8. High prevalence of diabetic retinopathy and nephropathy in Polynesians of Western Samoa. Collins VR, Dowse GK, Plehwe WE, Imo TT, Toelupe PM, Taylor HR, Zimmet PZ. Diabetes Care; 1995 Aug; 18(8):1140-9. PubMed ID: 7587849 [Abstract] [Full Text] [Related]
10. Relations between diabetic retinopathy and cardiovascular neuropathy--a cross-sectional study in IDDM and NIDDM patients. Zander E, Heinke P, Herfurth S, Reindel J, Ostermann FE, Kerner W. Exp Clin Endocrinol Diabetes; 1997 Aug; 105(6):319-26. PubMed ID: 9439926 [Abstract] [Full Text] [Related]
11. Management of newly diagnosed non-insulin-dependent diabetes mellitus in the primary care setting: effects of 2 years of gliclazide treatment--the Diadem Study. Cathelineau G, de Champvallins M, Bouallouche A, Lesobre B. Metabolism; 1997 Dec; 46(12 Suppl 1):31-4. PubMed ID: 9439556 [Abstract] [Full Text] [Related]
12. Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy. Parving HH, Nielsen FS, Bang LE, Smidt UM, Svendsen TL, Chen JW, Gall MA, Rossing P. Diabetologia; 1996 Dec; 39(12):1590-7. PubMed ID: 8960847 [Abstract] [Full Text] [Related]
13. Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus? Herrera-Pombo JL, Aguilar-Diosdado M, Hawkins F, Campos MM, Moreno A, Garcia-Hernandez A, Castro E, García-Doncel LG, Serraclara A, Sánchez-Malo C, Escobar-Jiménez F. Nephron Clin Pract; 2005 Dec; 101(3):c116-21. PubMed ID: 16015000 [Abstract] [Full Text] [Related]
14. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study. Cardoso CRL, Leite NC, Moram CBM, Salles GF. Cardiovasc Diabetol; 2018 Feb 24; 17(1):33. PubMed ID: 29477146 [Abstract] [Full Text] [Related]
15. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. Smulders YM, Rakic M, Slaats EH, Treskes M, Sijbrands EJ, Odekerken DA, Stehouwer CD, Silberbusch J. Diabetes Care; 1999 Jan 24; 22(1):125-32. PubMed ID: 10333913 [Abstract] [Full Text] [Related]
16. Chronic diabetic complications in patients with MODY3 diabetes. Isomaa B, Henricsson M, Lehto M, Forsblom C, Karanko S, Sarelin L, Häggblom M, Groop L. Diabetologia; 1998 Apr 24; 41(4):467-73. PubMed ID: 9562352 [Abstract] [Full Text] [Related]
17. U.K. Prospective Diabetes Study 22. Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM. Davis TM, Stratton IM, Fox CJ, Holman RR, Turner RC. Diabetes Care; 1997 Sep 24; 20(9):1435-41. PubMed ID: 9283793 [Abstract] [Full Text] [Related]
18. Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. Estacio RO, McFarling E, Biggerstaff S, Jeffers BW, Johnson D, Schrier RW. Am J Kidney Dis; 1998 Jun 24; 31(6):947-53. PubMed ID: 9631838 [Abstract] [Full Text] [Related]
19. Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study. Nielsen S, Schmitz A, Poulsen PL, Hansen KW, Mogensen CE. Diabetes Care; 1995 Nov 24; 18(11):1434-41. PubMed ID: 8722066 [Abstract] [Full Text] [Related]
20. Increased prevalence of elevated urinary albumin excretion rate in type 2 diabetic patients suffering from ischemic foot lesions. Zander E, Heinke P, Gottschling D, Zander G, Strese J, Herfurth S, Michaelis D. Exp Clin Endocrinol Diabetes; 1997 Nov 24; 105 Suppl 2():51-3. PubMed ID: 9288546 [Abstract] [Full Text] [Related] Page: [Next] [New Search]